Clinical effectiveness and toxicity of second-line irinotecan in advanced gastric and gastroesophageal junction adenocarcinoma: a single-center observational study.
about
Clinical effectiveness and toxicity of second-line irinotecan in advanced gastric and gastroesophageal junction adenocarcinoma: a single-center observational study.
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Clinical effectiveness and tox ...... le-center observational study.
@ast
Clinical effectiveness and tox ...... le-center observational study.
@en
type
label
Clinical effectiveness and tox ...... le-center observational study.
@ast
Clinical effectiveness and tox ...... le-center observational study.
@en
prefLabel
Clinical effectiveness and tox ...... le-center observational study.
@ast
Clinical effectiveness and tox ...... le-center observational study.
@en
P2093
P2860
P356
P1476
Clinical effectiveness and tox ...... le-center observational study.
@en
P2093
Agnieszka Julia Slowik
Andrzej Budzyński
Kamil Konopka
Mirosława Puskulluoglu
Sebastian Ochenduszko
P2860
P304
P356
10.1177/1758834016689029
P577
2017-02-07T00:00:00Z